All AbMole products are for research use only, cannot be used for human consumption.
LY255283 is a competitive leukotriene B4 receptor antagonist, with an IC50 of about 100 nM. It is somewhat selective for the BLT2 receptor, since IC50 values at the BLT1 receptor are >10 μM. LY255283 reduces airway obstruction in animal models of asthma.
| Molecular Weight | 360.45 |
| Formula | C19H28N4O3 |
| CAS Number | 117690-79-6 |
| Solubility (25°C) | DMSO: ≥20 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[4] S A Silbaugh, et al. Pulmonary actions of LY255283, a leukotriene B4 receptor antagonist
| Related Leukotriene Receptor Products |
|---|
| Pranlukast
Pranlukast is a selective cysteinyl leukotriene receptor antagonist. |
| Zafirlukast
Zafirlukast is a leukotriene receptor antagonist (LTRA) with IC50 of 0.6μM (IC50=7.0 µM for CYP2C9). |
| Cyclopentyl Chloroformate
Mandelic acid derivatives and their use as thrombin inhibitors. |
| CP-424174
CP-424174 is a cytokine release inhibitory compound (CRID) and also a reversible IL-1β inhibitor with an IC50 of 210 nM, which inhibits post-translational processing and secretion of IL-1β in human monocytes in the presence of LPS and ATP. |
| CP-105,696
CP-105,696 is an orally active, potent and selective leukotriene B4 receptor (LTB4R) antagonist (IC50 against [3H]LTB4 = 5. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
